Medtronic has recalled certain implantable cardioverter defibrillators and cardiac resynchronization therapy defibrillators due to a defect in the manufacturing process that may prevent them from delivering the electrical shock needed to pace a heartbeat or revive a patient in cardiac arrest, the Food and Drug Administration announced yesterday. In an urgent notice to affected customers, the company said to consider replacing implanted devices affected by the recall. Health care professionals may report adverse reactions or quality problems using the devices to FDA’s MedWatch program.
 

Related News Articles

Headline
Beginning in March, the Centers for Medicare & Medicaid Services will implement a streamlined survey and certification process for psychiatric hospitals,…
Headline
The Centers for Medicare & Medicaid Services has issued corrected preview reports for the Discharge to Community measure in the Long-term Care Hospital…
Headline
Inpatient rehabilitation facilities and long-term care hospitals can review their quality data through April 5 before it is reported on the IRF Compare …
Headline
The Food and Drug Administration, Centers for Disease Control and Prevention, and American Society for Microbiology yesterday released voluntary standardized…